Literature DB >> 3262763

Immunological separation of two CFU-GM subsets showing different responsiveness to T-cell derived growth factors.

C Tarella1, D Ferrero, D Caracciolo, R Badoni, G Bellone, E Gallo.   

Abstract

Among human myeloid precursors two different subpopulations can be distinguished: type-2 CFU-GM, more differentiated, reacting to the monoclonal antibody DSl-1 and type-1 CFU-GM, more immature, negative to the DSl-1. Using this monoclonal antibody, type-1 and type-2 CFU-GM were fractionated and separately grown in the presence of T-cell derived CSFs, i.e., conditioned medium of PHA-stimulated T-lymphocytes (PHA-Ly) and the supernatant of Il-2-dependent normal T-cell lines (TC-SN). The supernatants of two neoplastic non-T cell lines, TPA-30-1 and GCT, were used as control. PHA-Ly and TC-SN had a very weak activity on type-2 CFU-GM (18 and 14% of colony growth, compared to control). However, they potently stimulated type-1 CFU-GM (84 and 68.5% of colony growth, compared to control). The restricted activity of T-cell derived CSFs on early myeloid progenitors is therefore demonstrated. Our results also show that CFU-GM with different responsiveness to growth factors can be physically separated on the basis of their reactivity to monoclonal antibody DSl-1.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3262763

Source DB:  PubMed          Journal:  J Clin Lab Immunol        ISSN: 0141-2760


  2 in total

1.  Purification and characterization of two recombinant human granulocyte colony-stimulating factor glycoforms. Pharmacokinetic and activity studies of single-dose administration in mice.

Authors:  L Rotondaro; E De Paolis; D Ferrero; L D'Alatri; G Raucci; A Fabbri; G J Gerwig; J P Kamerling; M F Mariani; A Mele; R De Santis
Journal:  Mol Biotechnol       Date:  1999-04       Impact factor: 2.695

2.  Appropriate citation of placenta cell lines 3A(tPA-30-1) and 3A-sub E [post crisis of 3A(tPA-30-1)] in medical literature.

Authors:  Aiwa Ono; Paula Benny; Margaret Griffith; Christian Litton; Men-Jean Lee
Journal:  Heliyon       Date:  2020-10-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.